# Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma

> **NCT02537743** · — · COMPLETED · sponsor: **iOMEDICO AG** · enrollment: 98 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02537743
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-19
- **Primary completion:** 2021-02-19
- **Final completion:** 2021-02-19
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02537743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02537743, "Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02537743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*